CoreWeave: Extremely Undervalued With Sub-30 RSI

The article highlights CoreWeave (CRWV), an AI infrastructure provider, as a compelling investment opportunity following a recent 30% stock price decline. The company has demonstrated explosive growth, reporting a 420% year-over-year revenue increase in its latest quarter and projecting over $1 billion in FQ2 2025 sales, underpinned by a substantial $26 billion backlog. While not yet profitable, CoreWeave's adjusted EBITDA margin is expanding, and it is pursuing strategic growth, including the acquisition of Core Scientific. Key risks include significant customer concentration, with 72% of Q1 2025 revenue from a single client, and high capital intensity requiring ongoing financing.

Analysis

CoreWeave (CRWV) is positioned as a high-growth AI infrastructure provider that has recently experienced a significant stock price correction, declining nearly 30% over the last month with an RSI below 30, signaling a potentially oversold condition. The company's fundamental performance is characterized by explosive top-line growth, evidenced by a 420% year-over-year revenue increase in the last quarter and analyst expectations for sales to surpass $1 billion in FQ2 2025. This growth trajectory is supported by a substantial revenue backlog of almost $26 billion, providing strong forward visibility. While the company is not yet profitable on a net income basis, with positive EPS not expected until FQ2 2026, its adjusted EBITDA margin is expanding, improving from 55% to 62% year-over-year, which suggests increasing operational leverage. The growth strategy is multifaceted, including R&D investment and a pending all-stock acquisition of Core Scientific (CORZ). However, significant risks temper this outlook, most notably a severe customer concentration, with 72% of FQ1 2025 revenue from a single customer. Furthermore, the business is extremely capital-intensive, with quarterly capex exceeding revenue, necessitating future financing through debt or equity, which could pressure the stock.

Key Decisions for Investors

• Investors with a high tolerance for risk may view the recent 30% share price decline and oversold technical indicators as a tactical entry point to gain exposure to the secular growth in AI infrastructure.
• It is critical to monitor CoreWeave's progress in diversifying its customer base, as the current concentration of 72% of revenue from a single client presents a significant risk to future cash flows and valuation.
• Given the company's capital-intensive model and negative cash from operations, investors should closely track management's ability to fund its aggressive expansion and the terms of any future financing, which will likely be necessary to support growth.
• The pending acquisition of Core Scientific is a key strategic milestone; its regulatory approval and successful integration should be monitored as a critical test of the company's M&A execution capabilities.